Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumors

Khanh Do, Giovanna Speranza, Lun Ching Chang, Eric C. Polley, Rachel Bishop, Weimin Zhu, Jane B. Trepel, Sunmin Lee, Min Jung Lee, Robert J. Kinders, Larry Phillips, Jerry Collins, John Lyons, Woondong Jeong, Ramya Antony, Alice P. Chen, Len Neckers, James H. Doroshow, Shivaani Kummar

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences